Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study

被引：45

作者：

Torres, Tiago ^{[1
]}

Balato, Anna ^{[2
]}

Conrad, Curdin ^{[3
,4
]}

Conti, Andrea ^{[5
]}

Dapavo, Paolo ^{[6
]}

Ferreira, Paulo ^{[7
]}

Gaiani, Francesca ^{[8
]}

Leite, Luiz ^{[9
]}

Malagoli, Piergiorgio ^{[8
]}

Mendes-Bastos, Pedro ^{[7
]}

Megna, Matteo ^{[2
]}

Messina, Francesco ^{[10
]}

Nidegger, Alessia ^{[3
,4
]}

Odorici, Giulia ^{[5
]}

Piaserico, Stefano ^{[13
]}

Prignano, Francesca ^{[11
]}

Ribero, Simone ^{[6
]}

Ricceri, Federica ^{[11
]}

Tonini, Annalisa ^{[12
]}

Valerio, Joana ^{[9
]}

Chiricozzi, Andrea ^{[13
]}

机构：

[1] Ctr Hosp Univ Porto, Dept Dermatol, Porto, Portugal

[2] Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy

[3] CHU Vaudois, Lausanne Univ Hosp, Dept Dermatol, Lausanne, Switzerland

[4] Univ Lausanne, Lausanne, Switzerland

[5] Univ Modena & Reggio Emilia, Dept Dermatol, Modena, Italy

[6] Univ Turin, Dermatol Clin 2, Dept Biomed Sci & Human Oncol, Turin, Italy

[7] CUF Descobertas Hosp, Lisbon, Portugal

[8] Azienda Osped San Donato Milanese, Dermatol Unit, Milan, Italy

[9] Clin Med Belem, Lisbon, Portugal

[10] Univ Padua, Dept Dermatol, Padua, Italy

[11] Univ Florence, Dept Dermatol, Florence, Italy

[12] Univ Pisa, Dept Dermatol, Pisa, Italy

[13] Catholic Univ, Fdn Policlin Univ A Gemelli IRCCS, Inst Dermatol, Rome, Italy

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2019年 / 81卷 / 01期

关键词：

PLAQUE PSORIASIS;

D O I：

10.1016/j.jaad.2019.02.031

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

页码：273 / 275

页数：3

共 50 条

[1] Comment on "Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study''
Palacios-Garcia, Laura
Gomez-de Castro, Celia
Mir-Bonafe, Marc
Calzon, Cristina
Galache, Cristina
Santos-Juanes, Jorge
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (03) : E81 - E82
[2] Reply to: "Comment on 'Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study'''
Chiricozzi, Andrea
Torres, Tiago
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (03) : E83 - E83
[3] Drug survival of secukinumab in real-world plaque psoriasis patients: A 52-week, multicenter, retrospective study
Georgakopoulos, Jorge R.
Ighani, Arvin
Phung, Michelle
Yeung, Jensen
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (05) : 1019 - 1020
[4] Drug survival of secukinumab for psoriasis in a real-world setting
Lee, Erica B.
Amin, Mina
Egeberg, Alexander
Wu, Jashin J.
JOURNAL OF DERMATOLOGICAL TREATMENT, 2019, 30 (02) : 150 - 151
[5] Real-world drug survival of guselkumab, ixekizumab and secukinumab for psoriasis
Iznardo, H.
Vilarrasa, E.
Lopez-Ferrer, A.
Puig, L.
BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : 660 - 662
[6] Effectiveness and safety of secukinumab in Italian patients with psoriasis: an 84 week, multicenter, retrospective real-world study
Megna, Matteo
Di Costanzo, Luisa
Argenziano, Giuseppe
Balato, Anna
Colasanti, Paola
Cusano, Francesco
Galluccio, Antonia G.
Gambardella, Alessio
Lembo, Serena
Mozzillo, Raffaele
Di Luzio, Genoveffa Scotto
Fabbrocini, Gabriella
Balato, Nicola
EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (08) : 855 - 861
[7] Drug survival, discontinuation rates, and safety profile of secukinumab in real-world patients: a 152-week, multicenter, retrospective study
Ruiz-Villaverde, Ricardo
Rodriguez-Fernandez-Freire, Lourdes
Galan-Gutierrez, Manuel
Armario-Hita, Jose C.
Martinez-Pilar, Leandro
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2020, 59 (05) : 633 - 639
[8] Long-term efficacy, safety, and drug survival of secukinumab in patients with psoriasis in Turkey: a retrospective analysis of real-world experience
Yildirim, Fatma Elif
Hapa, Fatma Asli
POSTEPY DERMATOLOGII I ALERGOLOGII, 2024, 41 (01): : 49 - 55
[9] Treatment outcomes of secukinumab in adult patients with moderate-to-severe plaque psoriasis in China: A real-world multicenter retrospective study
Ding, Yangfeng
Li, Wei
Guan, Xin
Liu, Na
Zhou, Ying
Li, Gaojie
Wang, Xiaohua
Wang, Zhidong
Xiao, Xiao
Yang, Bin
Lv, Chengzhi
Zhang, Chunlei
Shi, Yuling
CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (10): : 1803 - 1814
[10] Drug survival of adalimumab biosimilars in real-world treatment of psoriasis: A Spanish multicenter study
Lopez-Ferrer, Anna
Vilarrasa, Eva
Armesto, Susana
Santos-Juanes, Jorge
Galache, Cristina
Carretero, Gregorio
Sahuquillo, Antonio
Salgado-Boquete, Laura
del Alcazar, Elena
Gonzalez-Cantero, Alvaro
Martorell, Antonio
Rivera-Diaz, Raquel
Mitxelena-Ezeiza, Josune
Mateu, Almudena
Belinchon, Isabel
Llamas-Velasco, Mar
Riera-Monroig, Josep
Lazaro, Anna
Lopez-Estebaranz, Jose Luis
Gich, Ignasi
Puig, Lluis
DERMATOLOGIC THERAPY, 2022, 35 (11)

← 1 2 3 4 5 →